Previous studies have shown that CXCR4 is highly expressed in NSCLC and is related to the prognosis of patients [21]; however, the same in both the LUAD and LUSC subgroups has not been shown before. This evidence concerns the gene CXCR4 and non-small cell lung carcinoma.